Short-term effects of enhanced treatment for depression in primary care:results from a randomized controlled trial by Smit, A et al.
  
 University of Groningen
Short-term effects of enhanced treatment for depression in primary care






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2006
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Smit, A., Kluiter, H., Conradi, HJ., van der Meer, K., Tiemens, BG., Jenner, JA., ... Ormel, J. (2006). Short-
term effects of enhanced treatment for depression in primary care: results from a randomized controlled
trial. Psychological Medicine, 36(1), 15-26. https://doi.org/10.1017/S0033291750600318
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Short-term eﬀects of enhanced treatment for
depression in primary care: results from a randomized
controlled trial
A. SMIT 1,2,3,4*, H. KLUITER 1, H. J. CONRADI 1,3,4, K. VAN DER MEER 1,5,
B. G. TIEMENS 2, J. A. JENNER 1,6, T. W. D. P. VAN OS 1 AND J. ORMEL 1,3,4
1 Department of Psychiatry, University of Groningen, Groningen, The Netherlands ; 2 Gelderse Roos Institute
for Professionalization Research, Wolfheze, The Netherlands ; 3 School of Behavioral and Cognitive
Neurosciences (BCN), University of Groningen, Groningen, The Netherlands ; 4 School of Experimental
Psychopathology (EPP),Maastricht University, Maastricht, The Netherlands ; 5 Department of General
Practice, University of Groningen, Groningen, The Netherlands ; 6 Mental Health Care Foundation Groningen,
The Netherlands
ABSTRACT
Background. Depression is a highly prevalent, often recurring or persistent disorder. The majority
of patients are initially seen and treated in primary care. Eﬀective treatments are available, but
possibilities for providing adequate follow-up care are often limited in this setting. This study
assesses the eﬀectiveness of primary-care-based enhanced treatment modalities on short-term
patient outcomes.
Method. In a randomized controlled trial we evaluated a psycho-educational self-management
intervention. We included 267 adult patients meeting criteria for a DSM-IV diagnosis of major
depressive disorder, assessed by a structured psychiatric interview. Patients were randomly assigned
to: the Depression Recurrence Prevention (DRP) program (n=112); a combination of the DRP
program with psychiatric consultation (PC+DRP, n=39); a combination with brief cognitive
behavior therapy (CBT+DRP, n=44); and care as usual (CAU, n=72). Follow-up assessments
were made at 3 months (response 90%) and 6 months (85%).
Results. Patient acceptance of enhanced care was good. The mean duration of the index episode
was 11 weeks (S.D.=9.78) and similar in CAU and enhanced care. Recovery rate after 6 months was
67% overall ; 17% of all participants remained depressed for the entire 6-month period.
Conclusion. Enhanced care did not result in better short-term outcomes. We found no evidence that
the DRP program was more eﬀective than CAU and no indications for added beneﬁcial eﬀects of
either the psychiatric evaluation or the CBT treatment to the basic format of the DRP program.
Observed depression treatment rates in CAU were high.
INTRODUCTION
Major depression is not only a serious and
highly prevalent disorder, its typical course
is recurrent or chronic (Ormel et al. 1990;
Judd, 1997; Lin et al. 1999; Mueller et al. 1999;
Simon, 2000; Solomon et al. 2000; van den
Brink et al. 2001; Spijker et al. 2002). It has
been estimated that more than 50% of
clinically depressed patients will have another
episode within 10 years and that those who have
experienced two episodes have an almost
90% chance of experiencing a third. Once
the disorder becomes recurrent, rates of relapse
may be as high as 40% within 4 months after
recovery (Keller, 1994). In around 20% of cases
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depression becomes a chronic disorder (Spijker
et al. 2000, 2002; van den Brink et al. 2001).
In The Netherlands, the majority of depressed
individuals are initially seen by their primary
care physician (PCP) and most of them continue
to be treated in primary care (Spijker et al. 2001;
Meijer et al. 2003; van der Linden et al. 2004).
Characteristic of the Dutch health-care system
is the open and unlimited access to a PCP,
the longitudinal continuity of the patient–PCP
relationship and the gatekeeper role of the
PCP, who controls access to specialist health
care for somatic as well as psychiatric con-
ditions. Eﬀective treatments for depression,
including pharmacological, psychotherapeutic
and supportive approaches, are available in
primary care (van Marwijk et al. 1994, 2003;
van Os et al. 1999). However, given the often
recurrent course of depression, the limited
possibilities for providing adequate follow-up
care and maintenance treatment in the primary-
care setting give reason for concern (Tiemens
et al. 1999; Ludman et al. 2003).
In the present paper, we report results on
short-term eﬀectiveness of enhanced treatment
in primary care on: duration of the index
episode, time to remission, recovery rates and
the percentages of patients free of any depress-
ive symptoms after 6 months. Core elements
of the Depression Recurrence Prevention (DRP)
program (Tiemens et al. 1998) include patient
education, three visits with a prevention
specialist and provider-initiated follow-up care,
consisting of monitoring of depressive symp-
toms and treatment adherence by telephone and
mail. Eﬀects of this enhanced care on the course
of depression and health-care use (including
the use of AD medication) are compared
with eﬀects of the care usually provided for
depression. Moreover, we evaluate whether
the addition of a psychiatric consultation or
brief cognitive behavior therapy to the basic
format of the DRP program, has any surplus
eﬀects.
METHOD
The DRP program was tested in a pragmatic
type randomized trial contrasting four condit-
ions : (1) care as usual (CAU), (2) the DRP pro-
gram, (3) the DRP program plus psychiatric
consultation (PC+DRP), (4) the DRP program
plus brief cognitive behavioral therapy (CBT+
DRP).
Setting
The settings for this study were PCP practices
in and around the city of Groningen, in the
northern part of The Netherlands. The selection
of PCPs was primarily guided by pragmatic
principles and circumstances, such as avail-
ability, the location of the practice, the number
of physicians sharing a practice and partici-
pation in earlier studies by the department.
No formal criteria applied for the inclusion.
Participating PCPs were invited to attend a
2-hour booster session about guidelines for
the treatment of depression in general practice
(van Marwijk et al. 1994; Jenner et al. 1995;
Schulberg et al. 1998). During these group
meetings the risk of depression turning into a
recurrent or chronic illness was emphasized and
implications for management in primary care
were discussed.
Patients
Main inclusion criterion was a current (i.e.
present in the past 2–12 weeks) diagnosis of
major depression according to DSM-IV criteria.
We excluded patients younger than 17 years
and older than 70 years of age, patients suﬀer-
ing from a life-threatening medical condition, a
psychotic disorder, dementia, and those with a
primary addiction to alcohol or psychotropic
drugs. In addition, women who were pregnant
or nursing and patients already receiving
treatment for depression elsewhere (i.e. by a
psychiatrist, psychologist or social worker) were
excluded.
Inclusion of patients was by a three stage-
procedure. First, participating PCPs were asked
to refer any patient whom they considered to be
depressed. Referral was based on the PCP’s
assessment on a brief symptom checklist on
which the DSM-IV criteria for major depression
were summarized; the checklist was provided
by the project. In the second stage research
assistants contacted the patients by telephone
to establish study eligibility. For conﬁrmation
of the PCP depression diagnosis we used a brief
screening instrument, containing the stem items
for major depression and dysthymia from the
Composite International Diagnostic Interview
(CIDI; WHO, 1997). Patients fulﬁlling study
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entry criteria were provided with detailed in-
formation on the study, verbally and in writing,
in order to obtain their consent. Patients
agreeing to enter the third step in the inclusion
procedure – thereby stating their willingness to
be randomized – were interviewed face to face
with the computerized lifetime version of the
CIDI. With this interview the ﬁnal diagnosis
leading to inclusion or exclusion was reached.
If the diagnosis was positive for depression the
patient entered the randomization procedure.
Randomization procedure and treatment
assignment
Randomization took place immediately at the
baseline appointment. We used a randomized
design stratiﬁed for use of antidepressants
(AD: yes/no) at baseline. Within each stratum,
patients were assigned to one of four conditions
by means of a computer-generated random
allocation list.
Once the diagnosis of major depression was
conﬁrmed by CIDI, the interviewer contacted
a research assistant by telephone. This assistant,
who had had no prior personal contact with the
patient, opened the ﬁrst sealed opaque envelope
from the appropriate set, representing the AD+
or ADx stratum, and passed the information
on treatment allocation on to the interviewer.
For patients assigned to one of the exper-
imental conditions time and place of the
ﬁrst session with the appropriate specialist
were scheduled. Patients assigned to the DRP
program received the educational materials
(book and videotape) that are an integral part of
the program. PCPs were informed about study
inclusion and the outcome of randomization
within 1 week of the baseline assessment.
Measures
All patients were followed up prospectively
for 3 years. Research assessments were made at
baseline and every 3 months thereafter. Follow-
up interviews were conducted by telephone by
trained research assistants using a laptop com-
puter. Each follow-up included a core set of
questions concerning the presence of depressive
symptoms and their course over time, the use
of AD medication, contacts with health-care
providers and competence in daily functioning.
The interviews were combined with several self-
report questionnaires every 6 months.
Depression status
At the baseline assessment, the full depression
and anxiety sections of the lifetime version of the
computerized CIDI (CIDI-auto; WHO, 1997;
Dutch version by Ter Smitten et al. 1998) were
included. The CIDI is a structured diagnostic
interview, with good reliability and validity
(Wittchen, 1994; Andrews & Peters, 1998) and
suitability for use in primary-care populations
(Ustun & Sartorius, 1995). We added questions
on the presence of (any residual) depressive
symptoms in the past 4 weeks to obtain a
full symptom proﬁle. To systematically record
onset and recency of depressive symptoms in
the follow-up interviews, we developed a brief,
structured and computerized interview measure
based on the CIDI. We examined treatment
eﬀects on duration of the index episode, time to
remission, recovery rates and the percentages
of patients free of any depressive symptoms
after 6 months. In accordance with the consen-
sus paper of Frank et al. (1991) and DSM-IV
criteria, remission is deﬁned as at least two
consecutive weeks without depression and
recovery as at least eight consecutive weeks
without depression.
The Beck Depression Inventory (BDI; Beck
et al. 1961) is included in each follow-up
to monitor depression severity. BDI scores <9
are generally seen as indicating normal, non-
depressed mood states, whereas BDI scores
o15 indicate a fully symptomatic depression
(Beck et al. 1988; Frank et al. 1991). The BDI
has good psychometric characteristics (e.g.
Hammen, 1997) and is also sensitive to change
over time (Richter et al. 1998).
Use of ADs, contacts with PCP and other care
utilization
Number of visits with the PCP and use of AD
medication were recorded at each follow-up.
In addition, we asked patients whether they
had received help from other (mental) health
providers, including ambulatory mental health
care and freely established psychologists and
psychiatrists in private practices.
Statistical analyses
Sample sizes were determined by power
analysis. We originally hypothesized the fol-
lowing gradient of outcome success, expressed
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in percentages of patients being recovered at
6 months : in CAU 60%, in DRP 70%, in
PC+DRP 80% of and in CBT+DRP 90%.
With 62 patients in CAU, 96 in DRP, 32
in PC+DRP and 36 in CBT+DRP these
outcomes would yield a Cramer’s w’ of 0.223,
corresponding with a satisfactory power of
81%.
To analyze diﬀerences between groups, we
used x2 tests for dichotomous variables and
t tests or non-parametric tests (Mann–Whitney,
Kruskal–Wallis) for continuous variables,
depending on their distribution. Change over
time in continuous outcome variables between
the treatment groups was tested by means
of repeated-measures ANOVAs. Where appro-
priate, full comparisons were supplemented
with pairwise comparisons. Survival analysis,
including the log rank test, was applied in
comparing the treatment groups as to the time
to recovery.
All analyses were based on intention to treat.
In addition, completer analyses were applied
where judged to be informative. We used SPSS
version 12 (SPSS Inc., Chicago, IL, USA).
Interventions
DRP program
The DRP program is a structured psycho-
educational intervention, based on an ongoing
relationship between the patient, a prevention
specialist and the PCP. The primary goal is to
reduce depression recurrence. The intervention
is aimed at increasing patients’ self-eﬃcacy with
regard to coping with depressive symptoms,
extending the potential of pro-active measures
and stress-management strategies and skills
to identify relapse or recurrence early on. The
focus is on improving patients’ resilience and
self-management skills (Smit et al. 2005).
The program consists of three individual
face-to-face sessions with a trained prevention
specialist, followed by four telephone monitor-
ing contacts per year for a 3-year period.
Prior to the ﬁrst session, patients receive a book
and corresponding videotape on depression,
treatment options, relapse prevention and
self-management strategies. At the last face-to-
face session, depression specialist and patient
prepare a patient-tailored depression preven-
tion plan, with the following topics : regular
self-registration of early warning signs ; stress
reduction strategies ; an ‘emergency plan’ ; and
a medication plan, for patients using ADs.
A copy of this plan is sent to the PCP. Main
goals of the standardized three-monthly follow-
up contacts are to systematically monitor de-
pressive symptoms, review patient progress and
to provide feedback and support. Motivational
interviewing (Miller & Rollnick, 2002) is used to
enhance conﬁdence in the patient’s ability to
succeed, to support self-eﬃcacy and strengthen
commitment to the program over time.
One psychiatric nurse and two psychologists,
all females, were trained by two experts from the
Seattle project to deliver the enhanced treatment
program. Adherence to the DRP protocol was
monitored in regular supervision sessions with a
psychiatrist who had also attended the training.
The prevention specialists used standardized
forms for each patient contact. During the ﬁrst
phase, they provided the PCP with written
feedback of each session, and in the follow-up
phase they kept a record of all patient contacts.
The intervention was developed by Katon
and co-workers at the Center for Health Studies
of the University of Washington in Seattle, USA
(Katon et al. 1996; Ludman et al. 2000) and
adapted for use in The Netherlands by Tiemens
and colleagues (Tiemens et al. 1998). For a
more detailed description we refer to Smit et al.
(2005).
PC+DRP program
Patients in the PC+DRP group were oﬀered
one 1-hour visit with one of two available
psychiatrists, prior to the DRP program. The
PCP provided the psychiatrist with information
about the patients’ health and treatment status.
Afterwards, the psychiatrist reported his diag-
nostic ﬁndings and treatment advice to the
PCP. A copy of this written report was also
made available to the prevention specialist. The
main purpose of the psychiatric consultation
was to make more speciﬁc psychiatric expertise
on diagnosis and pharmacological treatment of
depression available for use in primary-care
practice.
CBT+DRP program
The CBT+DRP group was oﬀered 10–12
individual weekly 1-hour sessions of CBT
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treatment, tailored to primary care by Boelens
(1997). The DRP program started after the ﬁnal
CBT session. The CBT therapist informed the
prevention specialist about the main themes that
the CBT had addressed and the progress
achieved.
Three qualiﬁed CBT therapists were em-
ployed. To reinforce concepts and CBT tech-
niques and to monitor their adherence to the
protocol, regular supervision sessions were
held. The acting supervisor was the regional
CBT expert who developed the treatment
protocol.
The main purpose of including CBT was that
this has been found to be an eﬀective treatment
for depression and there are indications that
CBT may reduce relapse rates (Fava et al. 1998;
Paykel et al. 1999; Scott et al. 2000). However,
studies on CBT in primary-care patients are
scarce and results are not consistent (see Scott
et al. 1997; Ward et al. 2000).
CAU
Patients assigned to the usual care group were
referred back to their own PCP and received
the care that this PCP deemed appropriate.
In most cases, this included a combination of
AD medication and counseling during regular
visits (van Os et al. 1999). As in current practice
PCPs were free to refer patients to any service
normally available, such as social workers,
private practice psychiatrists or psychologists,
or specialized mental health agencies.
RESULTS
PCPs
A total of 55 PCPs in the northern part of
The Netherlands agreed to participate. The
mean number of patient referrals per PCP was
7.2, but there were considerable diﬀerences
between PCPs in this respect (range 1–43); 13
PCPs (24%) referred 10 or more patients. The
mean number of included patients per PCP was
5.5 (range 1–35); of eight PCPs, 10 or more
patients were included. The ﬁnal study group
consists of 267 patients from 49 PCPs.
Patients
Of 397 patients who were identiﬁed as depressed
by their PCP and referred to the study, 323
(81.4%) agreed to the screening procedure.
The majority (n=277, 85.8%) was eligible and
willing to take part in the study (see Fig. 1).
On the baseline assessment 10 patients were
excluded because they did not fulﬁll study entry
criteria. Thus, a total of 267 patients, compris-
ing 67% of all initially referred patients and
83% of those who could be contacted and
screened, met the inclusion criteria and were
randomly assigned to one of the four treatment
conditions. 72 patients (27%) were assigned
to CAU and 195 patients were assigned to the
enhanced care program: 112 patients (57%)
were oﬀered the DRP program only, 39 patients
(20%) were assigned to PC+DRP and another
44 patients (23%) were assigned to the brief
CBT followed by DRP.
The percentages of respondents at the
follow-up were 90% after 3 months and 85%
after 6 months. These rates were similar between
treatment groups.
Baseline characteristics
In Table 1, sociodemographic and clinical
characteristics of the baseline sample are sum-
marized. Randomization proved to be success-
ful ; there were no signiﬁcant diﬀerences on any
of these characteristics between patients in the
four treatment groups.
Patient acceptance of treatment assignment
Overall, 92% of the intervention patients
attended all three individual face-to-face
sessions with a depression prevention specialist ;
94% attended at least one. Participation in
this phase was highest among patients random-
ized to the DRP program only (96%) and
in those assigned to PC+DRP (97%), but
lower in the group where DRP followed after
CBT (75%; x2=23.97, df=2, p<0.0001).
In the 6 months after the last session,
prevention specialists remained in contact with
the vast majority of the patients, with 98%
returning their mail and responding to both of
the telephone calls.
With regard to the additional treatments
by mental health specialists, all 39 patients
randomized to PC+DRP agreed to the visit
with the psychiatrist. In comparison, com-
pliance with CBT was lower: 33 of the 44
patients assigned to CBT completed this treat-
ment (75%), while three patients refused and
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eight dropped out prematurely (after a mean of
four sessions).
Depression outcome
As shown in Table 2, we found no evidence that
enhanced care was more eﬀective than CAU
in the short term. After 27 weeks the recovery
rate was 66% and similar among CAU and
enhanced care patients. A total of 17% of study
participants remained depressed during this
entire period.
Time to recovery
The mean duration of the index depressive
episode was 11 weeks (S.D.=9.78) and similar
in CAU and enhanced care patients (see Fig. 2).
Depression severity (BDI)
BDI scores improved the most in the ﬁrst
3 months (on average 6.81 points), and the
percentage of patients scoring above the
threshold (BDI o15) fell from 69% to 38%
overall at the 6-month follow-up. We found











CAU: 72 DRP: 112 PC + DRP: 39
3-mo. FU: 343-mo. FU: 1023-mo. FU: 64
6-mo. FU: 62 6-mo. FU: 96 6-mo. FU: 32 6-mo. FU: 36
3-mo. FU: 40
CBT+DRP: 44
FIG. 1. Flowchart. PCP, Primary care physician; CAU, Care as usual ; DRP, Depression Recurrence Prevention program;
PC+DRP, psychiatric consultation plus DRP; CBT+DRP, cognitive behavior therapy plus DRP; FU, follow-up.
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% Female 65 65 69 54
Age (yr), mean (S.D.) 44.2 (11.3) 42.5 (10.6) 41 (13.0) 42.8 (11.6)
Marital status (%)
Married/cohabiting 68 69 67 48
Single 13 18 18 34
Divorced 15 10 15 14
Widowed 4 4 — 5
Primary role (%)
Employed 56 65 59 57
Homemaker 25 17 21 14
Student 4 5 8 7
Unemployed 7 6 5 14
Disabled 6 6 3 9
Retired/other 3 1 5 —
Educational attainment (%)
Low 49 42 46 39
Medium 29 41 33 39
High 22 17 21 23
Severity rating current MDD (%)
Mild 28 32 36 23
Moderate 24 38 28 32
Severe 49 30 36 39
Recurrent DSM-IV MD (%) 74 64 64 68
If recurrent : %>3 episodes 57 51 56 60
Age at ﬁrst onset (yr),
mean (S.D.)
32.4 (14.3) 30.9 (11.8) 30.6 (15.4) 31.1 (13.2)
Suicide attempt, ever (%) 13 8 10 12
BDI, mean (S.D.) 18.9 (9.49) 20.6 (9.32) 20.3 (9.84) 20.3 (9.25)
% Co-morbid, currenta
Dysthymic disorder 3 12 10 8
Panic disorder 13 13 15 11
Agoraphobia 8 6 13 9
Social phobia 14 17 15 14
CAU, Care as usual ; DRP, Depression Recurrence Prevention program; PC+DRP, psychiatric consultation plus DRP; CBT+DRP,
cognitive behavior therapy plus DRP.
a Current : present in past month.
No statistically signiﬁcant diﬀerences (p<0.05).











% recovered 68 61 79 70 67
Duration index episode,
in weeks, mean (S.D.)
10.7 (9.9) 11.8 (10.0) 9.3 (8.2) 11.2 (10.6) 11.0 (9.8)
% patients remitted at
least once
25 28 15 18 21
% depressed full
27 weeks
17 20 6 15 17
% with neither
remission or recovery
20 23 12 20 20
CAU, Care as usual ; DRP, Depression Recurrence Prevention program; PC+DRP, psychiatric consultation plus DRP; CBT+DRP,
cognitive behavior therapy plus DRP.
Recovery, no diagnosis for at least 8 weeks. Remission, no diagnosis, lasting 2–7 weeks.
No statistically signiﬁcant diﬀerences (p<0.05). We also performed additional pairwise comparisons (no statistically signiﬁcant diﬀerences ;
results available on request).
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no statistically signiﬁcant diﬀerences in the
comparisons between treatment groups.
Treatment : AD medication and additional
health-care use
At the 3-month follow-up, AD use was
signiﬁcantly lower in patients assigned to
CBT+DRP, compared with CAU and both
other DRP groups (Table 3). At the 6-month
follow-up, AD use in CBT patients remained
signiﬁcantly lower compared with that of
PC+DRP patients. The majority of patients
remained in touch with their PCP during the
ﬁrst 6 months, but this proportion was lowest
in the CBT+DRP group. Additional mental
health-care use was diﬀerent for CAU and
enhanced care patients, with CAU patients
receiving more specialist mental health care by
freely established psychologists, ambulatory
mental health-care or social workers. In the
period between the 3- and 6-month follow-up,
when most enhanced care patients ﬁnished the
ﬁrst phase of the DRP program, the number of
DRP patients receiving other mental health-care
also rose.
DISCUSSION
The DRP program aims at integrating
treatment for the acute episode and the preven-
tion of depression relapse and recurrences.
Patients included in this trial suﬀered from
recurrent depression. The short-term outcome
data presented in this paper reﬂect initial
response to treatment and show hardly any
contrasts between the CAU and enhanced care
patients. Several explanations should be con-
sidered for this lack of diﬀerence.
Foremost of course, the DRP program and
its combinations with either a psychiatric
consultation or brief CBT may not have been
capable or powerful enough to add to the eﬀects
already achieved by usual care. We saw high
depression treatment rates in CAU, especially
in the interval between study inclusion and the
3-month follow-up, which may mean that most
patients already received optimal and guideline-
concordant treatment from their PCP.
At baseline, AD use was almost 75% overall.
At follow-up, medication adherence rates in the
CAU, DRP and PC+DRP patients were higher
than anticipated. Although poor compliance
with drug treatment is frequently reported as a
problem (Pampallona et al. 2002), especially in
primary care (Lawrenson et al. 2000), this did
not seem to be the case in the present study.
Thus, with the exception of CBT+DRP (there
was no speciﬁc focus on medication compliance
in the CBT protocol), rates of both initial AD
use as well as adherence are higher than found
in previous primary-care studies. This may be
explained in several ways. First, relevance of
medication adherence was a subject dealt with
explicitly in the DRP program. Second, because
of the experience of multiple episodes, patients
may have been more willing to accept AD con-
tinuation treatment for their present episode.
Third, AD treatment seems to have become a
more routine practice in Dutch primary-care
settings. Data from national studies show that
PCPs are responsible for the majority (78%)
of prescriptions for ADs in The Netherlands
and that the number of these prescriptions
has increased substantially year by year (van
Marwijk et al. 2001; CVZ, 2003). Laurant
and colleagues (2004) report that in 68% of
PCP-diagnosed depressive episodes an AD
was prescribed. Furthermore, the majority of




















FIG. 2. Time to recovery (Kaplan–Meier curve). Numbers cen-
sored: CAU, 19; DRP, 31; PC+DRP, 8; CBT+DRP, 12. Log
rank: 1.74, df=3, p=0.63. Median survival time: CAU, 10; DRP,
10; CBT+DRP, 11; PC+DRP, 10.
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patients in our study visited their PCP regularly.
Data on PCP prescribing behavior demon-
strates that the increase in AD prescriptions
occurred mainly during repeat consultations
(van Marwijk et al. 2001; van Os et al. 2002).
In addition, recent ﬁndings conﬁrm that AD
adherence among primary-care patients seems
to have become less problematic. Brook and
co-workers (2005) studied the eﬀects of a
pharmacy-based program on improving adher-
ence to AD treatment in primary care and
found 6-month adherence rates of 73% in
CAU (and 76% in the experimental group).
The referral rates to specialized mental health
care also deserve attention. The fact that during
the ﬁrst 6 months more than one third of CAU
patients received some form of specialist care
may have been a side-eﬀect of the study, in two
ways: (1) a number of PCPs may have ‘used’
the selection procedure primarily for diagnostic
purposes, i.e. to get their suspicions conﬁrmed;
once this happened they may have seen referral
of the patient as the most appropriate reaction;
(2) patients assigned to usual care may have
been disappointed by this randomized assign-
ment and sought treatment elsewhere, whether
or not by formal referral. However, these ﬁg-
ures may also reﬂect the growing tendency in
The Netherlands for PCPs to refer patients with
a psychological diagnosis to more specialized
mental health agencies, including private-
practice psychologists (Verhaak et al. 2000;
Meijer et al. 2003).
After ﬁnishing the ﬁrst phase of the DRP
program, the number of enhanced care patients
receiving specialized mental health care also
rose. This could have been due to the same
shift described above, with more patients being
referred. Patient preferences may also be of
importance, since available studies show that
many patients prefer psychotherapy in the
treatment of depressive disorders (van Schaik
et al. 2004). Furthermore, given that most
patients had already experienced more episodes,
lack of conﬁdence in their own abilities to
successfully overcome depression and prevent
future episodes may also explain this help-
seeking behavior. We found indications for a
persistent lack of self-conﬁdence in dealing
with depression in 3-month follow-up scores
on a self-eﬃcacy questionnaire (DSES; Bush
et al. 2001), where scores remained low overall
and there was no evidence that enhanced
care patients beneﬁted more from their treat-
ment than patients receiving CAU (Smit et al.
2005).
Table 3. Treatment : antidepressant (AD) use and health-care utilization
CAU DRP PC+DRP CBT+DRP
AD use at baseline (%)a
(n=267)
76 74 72 73
AD use at 3-month follow-up (%)b
(n=240)
72 70 74 50
AD use at 6-month follow-up (%)c
(n=226)
60 59 69 42
Between baseline and 3-month follow-up (%)
Visited PCP at least onced 94 85 79 58
Number of visits (mean) 2.9 3.3 3.8 3.2
Additional mental health caree 39 19 24 10
Between 3- and 6-month follow-up (%)
Visited PCP at least oncef 66 78 69 61
Number of visits (mean) 2.4 2.2 2.5 1.8
Additional mental health careg 34 31 19 11
CAU, Care as usual ; DRP, Depression Recurrence Prevention program; PC+DRP, psychiatric consultation plus DRP; CBT+DRP,
cognitive behavior therapy plus DRP.
a For numbers see Fig. 1.
b CBT+DRP versus CAU (x2=5.08, df=1, p=0.02). CBT+DRP versus DRP (x2=4.80, df=1, p=0.03). CBT+DRP versus PC+DRP
(x2=4.27, df=1, p=0.04).
c CBT+ DRP versus PC+DRP (x2=5.01, df=1, p=0.03).
d x2=23.24, df=3, p<0.001.
e x2=14.09, df=3, p=0.003.
f CBT+DRP versus DRP (x2=3.89, df=1, p=0.05).
g x2=8.08, df=3, p=0.04; CAU versus CBT+DRP (x2=6.21, df=1, p=0.01).
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Strengths and limitations
Our study has several strengths. Since the aim
is to ﬁnd information on the eﬀectiveness of
the intervention, patient inclusion criteria were
not very stringent. This permitted the majority
(83%) of patients who where screened after
being referred by their PCP to enter the trial.
Also, more than 50 PCPs were willing to
participate. Several researchers (Fairhurst &
Dowrick, 1996; Hunt et al. 2001) have found
this kind of participation hard to achieve.
Randomization was successful, with similar
demographic and clinical characteristics in
all four arms of the study. Acceptance of
the interventions was high. CBT and PC are
common referral options for treatment of
depression, which increases the relevance of our
ﬁndings for primary-care practice. Our method
of establishing depression status at each follow-
up enabled us to systematically record current
symptoms week by week, follow the course of
existing symptoms and trace the onset of ‘new’
ones. Last, but certainly not least, follow-up
response rates were good.
By deﬁnition, conducting a pragmatic trial
implies that several factors are beyond the
control of the researchers. Participating PCPs
were free to manage the CAU and enhanced
care patients as they saw ﬁt. We did not inﬂu-
ence or determine their treatment decisions.
Referral rates for CAU patients seemed high,
although we now ﬁnd that they may also reﬂect
current primary-care practice. Selection of the
PCPs was not random, and participating PCPs
may have been more interested in the subject of
depression treatment and relapse prevention
than the average PCP. Patient recruitment was
slower than anticipated and we needed more
time than originally planned to enroll enough
patients. During this recruitment period, lasting
3.5 years in total, the observed changes in
referral behavior and the prescription of ADs
may have become more routine practice for
depression management by PCPs. Another
limitation is that, while the study had suﬃcient
power to test the gradient of the outcome-
success hypothesis, pairwise comparisons of
the PC and CBT arms with CAU or DRP are
probably underpowered. There appeared to be
a trend towards more positive outcomes in
the PC+ DRP group, but on the other hand,
observed diﬀerences were small and it can be
questioned whether they are clinically relevant.
Finally, it was not possible to blind interviewers
from the treatment status of the participants.
CONCLUSION
Although well-received and appreciated by
patients and PCPs, we found no evidence that
the DRP program was more eﬀective than CAU
in the short term. Three and 6 months into the
trial period, we found similar depression rates in
enhanced care and CAU patients, but it should
be noted that depression treatment rates in
CAU were high. In addition, we found hardly
any indications for added beneﬁcial eﬀects of
either the psychiatric evaluation or the CBT
treatment to the basic format of the DRP
program. Thus, enhanced care did not result
in better depression outcomes in the short
term. However, given that the follow-up care
provided in the context of the DRP program
continues for 3 years, it might be that beneﬁts of
this enhanced care over CAU will only become
clear after a more prolonged period.
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